Experts in infectious disease, pulmonology, cardiology, neurology, and psychiatry share their perspectives on the phenomenon that is long COVID-19.
Lifestyle behavior treatment should be the first-line treatment for patients with mildly elevated blood pressure and cholesterol.
A team of investigators conducted a population-based cohort study to determine whether preeclampsia history affected the relative risk for incident stroke.
The effects of hybrid comprehensive telerehabilitation compared with usual care were analyzed in a cohort of patients with HFrEF.
Consuming low-quality carbohydrates and animal protein at dinner versus breakfast linked to increased CVD risk
Sixty-nine of 78 participants with type 2 diabetes on treatment for hypertension stopped all or some antihypertensive and diuretic medications.
APP discusses the benefits of early integration of palliative care in patients with cancer as well as chronic heart, lung, and neurologic diseases.
Researchers aimed to study the associations between heart failure medications and certain systemic autoimmune rheumatic diseases.
Though uncommon, cases of new heart failure include younger COVID-19 patients with no history of cardiovascular disease or risk factors
Sinus tachycardia is the most commonly reported dysrhythmia in patients with COVID-19 disease.
Heart failure patients have significantly higher likelihood of developing depression within five years
Obesity, elevated blood pressure prevalent in younger Black women, even those in their 20s and 30s
Greater variability in systolic blood pressure and diastolic blood pressure was associated with increased CVD mortality risk in T2D.
High-strength magnets may cause implants to switch to ‘magnet mode,’ stopping normal functioning until the magnet is moved away from the device
Should cardiologists be looking at patients’ mental health as well as their physical health? Research has suggested that a patient’s mental health disorder and outlook may play a role in cardiovascular health. What are the different ways mental health affects cardiovascular disease?
CVST with thrombocytopenia reported after COVID-19 vaccine with adenoviral vector; management similar to heparin-induced thrombocytopenia
Investigators sought to determine the prevalence of small intestinal bacterial overgrowth and establish its prognostic value in patients with heart failure.
POCUS suggested in addition to standard diagnostic pathway for patients with acute dyspnea in ED, inpatient setting when diagnosis is uncertain
Patient-reported outcomes are a more sensitive measure than NYHA functional class for assessing changes in health status in HFrEF.
Consideration should be given to addition of meds for adults not meeting BP goals after 6 months of lifestyle therapy